COMMUNIQUÉS West-GlobeNewswire

Akorn Names Douglas S. Boothe as President and CEO
20/12/2018
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Douglas S. Boothe has been named president and chief executive officer effective January 1, 2019, bringing deep [...]
Helix BioPharma Corp. Closes Second Tranche of Private Placement
20/12/2018
RICHMOND HILL, Ontario, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018
20/12/2018
BEIJING, Dec. 20, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
ContraFect to Present at Biotech Showcase 2019
20/12/2018
YONKERS, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment
20/12/2018
- Sites to continue enrollment up to 250 patients in sexual function trial - ENGLEWOOD, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's [...]
Merus Announces Global Settlement and End to All Patent Litigation with Regeneron Pharmaceuticals
20/12/2018
Merus and Regeneron to cross-license patents relating to certain antibody generation platform technologies Regeneron to purchase $15 million of Merus common shares UTRECHT, The Netherlands, Dec. 20, 2018 (GLOBE NEWSWIRE [...]
Imagin Medical Reports Fiscal Year End 2018 Results
20/12/2018
VANCOUVER, British Columbia and BOSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results [...]
Dova Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/12/2018
DURHAM, N.C., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (Nasdaq: DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where there is a [...]
The Cooper Companies to Present at J.P. Morgan Healthcare Conference
20/12/2018
PLEASANTON, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 8, 2019. Albert G. White III, [...]
The Cooper Companies Sets Annual Meeting and Stockholder Record Dates
20/12/2018
PLEASANTON, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that it will hold its next annual meeting of stockholders on Monday, March 18, 2019. Stockholders of record as [...]
Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program
20/12/2018
NOGALES, Ariz., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Nogales, Arizona – December 20, 2018, Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and [...]
SI-BONE to Present at the 37th Annual J.P. Morgan Healthcare Conference
20/12/2018
SANTA CLARA, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant [...]
ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®
20/12/2018
ChromaDex Corporation and Nestlé Health Science agreement includes global commercial license and supply agreement for ingredient sales of TRU NIAGEN® for certain products within the medical nutrition and consumer health [...]
ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
20/12/2018
Phase 3 atrial fibrillation trial planned in population with no effective or FDA approved therapies PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably to Gencaro [...]
Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of C3 Glomerulopathy
20/12/2018
CRESTWOOD, Ky. and WALTHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. , (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Tetra Successfully Completes Phase 1 Study With Vaporized Version of PPP001
20/12/2018
Planning for Phase 2 Clinical Trial Underway OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”) today announced that its Phase 1 clinical trial in healthy volunteers using vaporized [...]
Flexion Therapeutics to Report Preliminary Unaudited 2018 Revenue and Provide 2019 Revenue Guidance on January 3, 2019
20/12/2018
BURLINGTON, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) will announce preliminary unaudited revenue for the fourth-quarter and full-year 2018 and provide revenue guidance for 2019 [...]
Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer
20/12/2018
EMERYVILLE, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Corizon Health to Partner With the State of Maryland
20/12/2018
Transition to occur New Year’s Day BRENTWOOD, Tenn., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Corizon Health will be ringing in the New Year with a contract to provide inmate healthcare services to the State of Maryland. The [...]

Pages